Are plasma homocysteine levels related to neurological severity and functional outcome after ischemic stroke in the Korean population?

被引:20
作者
Song, In-Uk [1 ]
Kim, Joong-Seok [1 ]
Ryu, Seon-Young [1 ]
Lee, Sang-Bong [1 ]
Lee, Seung-Jae [1 ]
Jeong, Du-Shin [2 ]
Kim, Yeong-In [1 ]
Lee, Kwang-Soo [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Neurol, Seoul, South Korea
[2] Soonchunhyang Univ, Coll Med, Dept Neurol, Seoul, South Korea
关键词
Plasma homocysteine; Functional disability; Prognosis; ACUTE CORONARY SYNDROMES; C-REACTIVE PROTEIN; RISK-FACTOR; ELDERLY PERSONS; ARTERY-DISEASE; MORTALITY; JAPANESE; HYPERHOMOCYSTEINEMIA; PROGNOSIS; EVENTS;
D O I
10.1016/j.jns.2008.11.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hyperhornocysteinemia is known to be an independent risk factor for arteriosclerosis. However, the prognosis of functional disability in cerebrovascular disease has not been well established. Therefore, we conducted this Study to determine the prognostic significance of plasma homocysteine (Hcy) levels in Asian patients with functional disabilities after acute ischemic stroke. A total of 267 patients were examined within 24 h after symptom onset. Hcy was measured at admission. The correlations between plasma Hcy concentration and functional disability at 1-month, 3-months, 6-months, and 12-months after stroke onset were analyzed. In addition, the associations between each risk factor for stroke or neurological severity and plasma Hcy level were evaluated. The results of the present study showed that there was no significant correlation between Hcy level on admission and modified Rankin Scale score obtained at 1-month, 3-months, 6-months, and 12-months after stroke onset. There was also no association between plasma Hcy level and neurological severity after stroke or stroke subtype. This study showed that there is no association between Hcy levels and functional outcome after stroke. Therefore, we cautiously assert that plasma Hcy levels have no value as predictors of functional disability in Asian patients with stroke. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:60 / 63
页数:4
相关论文
共 28 条
[11]  
JEONG DS, 1999, J KOR NEUROL ASS, V17, P26
[12]   Homocysteine levels and decline in physical function: MacArthur studies of successful aging [J].
Kado, DM ;
Bucur, A ;
Selhub, J ;
Rowe, JW ;
Seeman, T .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (07) :537-542
[13]   Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons - The Cardiovascular Health Study [J].
Longstreth, WT ;
Katz, R ;
Olson, J ;
Bernick, C ;
Carr, JJ ;
Malinow, MR ;
Hess, DL ;
Cushman, M ;
Schwartz, SM .
ARCHIVES OF NEUROLOGY, 2004, 61 (01) :67-72
[14]   Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke [J].
Meiklejohn, DJ ;
Vickers, MA ;
Dijkhuisen, R ;
Greaves, M .
STROKE, 2001, 32 (01) :57-62
[15]   Plasma homocysteine level and functional outcome of patients with ischemic stroke [J].
Mizrahi, EH ;
Fleissig, Y ;
Arad, M ;
Adunsky, A .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2005, 86 (01) :60-63
[16]   Plasma homocysteine levels and mortality in patients with coronary artery disease [J].
Nygard, O ;
Nordrehaug, JE ;
Refsum, H ;
Ueland, PM ;
Farstad, M ;
Vollset, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04) :230-236
[17]  
Okamura T, 1999, J CARDIOVASC RISK, V6, P371
[18]   Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians [J].
Okubadejo, Njideka U. ;
Oladipo, Olajumoke O. ;
Adeyomoye, Adekunle A. ;
Awosanya, Gbolahan O. ;
Danesi, Mustapha A. .
BMC NEUROLOGY, 2008, 8 (1)
[19]   Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes [J].
Omland, T ;
Samuelsson, A ;
Hartford, M ;
Herlitz, J ;
Karlsson, T ;
Christensen, B ;
Caidahl, K .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (12) :1834-1840
[20]   Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease [J].
Perini, F ;
Galloni, E ;
Bolgan, I ;
Bader, G ;
Ruffini, R ;
Arzenton, E ;
Alba, S ;
Azzini, C ;
Bartolomei, L ;
Billo, G ;
Bortolon, F ;
Dudine, P ;
Garofalo, PG ;
L'Erario, R ;
Morra, M ;
Parisen, P ;
Stenta, G ;
Toso, V .
NEUROLOGICAL SCIENCES, 2005, 26 (05) :310-318